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Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease 
of the central nervous system (CNS), characterised by the 
presence of demyelinating white matter lesions (WML). 
WML can be detected using magnetic resonance imaging 
(MRI): They are seen as areas of high signal intensity on 
proton density-weighted (PDw) and T2-weighted (T2w) 
magnetic resonance (MR) images (T2-WML). However, 
studies show that the volume of T2-WML correlates only 
modestly with clinical disability, a phenomenon referred 
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to as a clinico-radiologic paradox.1 The observed dissoci-
ation has been attributed, in part, to the inability of PDw 
and T2w MRI to identify the underlying pathologic het-
erogeneity of T2-WML, but also to factors other than 
T2-WML.
Whilst a plethora of in vivo MR studies aim to character-
ise the underlying pathological processes that exist beyond 
T2-WML, i.e. in normal-appearing white matter (NAWM)2–7 
and dirty-appearing white matter (DAWM),8–11 in an effort 
to explain the observed clinico-radiological dissociation 
pertaining to T2-WML volume measurements, very little 
work probes the pathological tissue heterogeneity that 
exists within and between WML that are seen on routine 
PDw and T2w images. The possible contribution of such 
findings toward resolving the clinico-radiologic dissocia-
tion currently remains unknown.
ADvanced IMage Algebra (ADIMA) is a novel MR 
image-processing method that utilises conventional PDw 
and T2w data-sets to classify all WML on these images into 
either ‘bright’ or ‘dark’ ADIMA sub-regions, which can be 
easily segmented, reflecting underlying tissue heterogenei-
ties that have not been previously investigated. In this pub-
lication, the ADIMA method is described along with the 
results from preliminary investigations to (a) assess the 
reproducibility of segmenting the ADIMA-derived regions, 
(b) determine any correlations between the ADIMA-
derived volumes and conventional lesion volumes, i.e. 
T2-WML and T1-WML and (c) characterise the properties 
of the underlying tissue within these ADIMA-derived 
regions, by means of quantitative MRI, i.e. T1, T2 and 
magnetisation transfer ratio (MTR).
Materials and methods
The ADIMA method
The technique of ‘pseudo-T1’ image contrast is reported in 
the literature.12 Typically, a pseudo-T1 image is obtained 
through a pixel-by-pixel subtraction of the late echo image 
seen in a conventional fast-spin echo (FSE) dual-echo 
(T2w) data-set from the corresponding early echo (PDw), 
yielding an image that appears qualitatively similar to a 
conventional T1-weighted image (T1w), that is, the cere-
brospinal fluid (CSF) and lesions having long T2 relaxa-
tion times appear hypointense, relative to NAWM (see 
Figure 1). The PDw and T2w images are acquired with a 
dual-echo sequence, which means they are co-registered 
and have the same transmitter and receiver gain settings. 
The pseudo-T1 image contains both negative and positive 
pixel values.
The ADIMA method’s rationale is based on expanding 
the dynamic range of signal intensities in the final ADIMA 
image, in order to visualise subtle differences within tissue 
types. This is achieved by applying a normalisation opera-
tion to both the pseudo-T1 and the original PDw image 
(referred to as image in equation (1)). If max_a = max 
(image) and min_a = min (image), then:
image_normalised = (image - min_a) / (max_a - min_a) (1)
During the operation in equation (1), the images are nor-
malised from the original 16-bit signed integer arrays of the 
PDw image and the pseudo-T1 image, into double-preci-
sion arrays with values in the range 0–1. Next, the absolute 
intensity difference between the two is calculated to obtain 
the ADIMA image as follows in equation (2):
ADIMA_image =  |PDimage_normalised –  
pseudoT1_normalised| (2)
Without the normalisation step, equation (2) would lead 
to the original T2w image, but because of the operation 
described in equation (1), the image resulting from the 
subtraction described in equation (2) exhibits differences 
of signal intensities that are otherwise not visible on the 
individual PDw, T2w and pseudo-T1 images. Within 
WML, these differences can be classified into subsets of 
bright (ADIMA-b) and dark (ADIMA-d) regions, which 
can be segmented using manual or semi-automated seg-
mentation methods (see Figure 2). Henceforth, ADIMA-
abnormal regions are defined as areas of hyper or 
hypointensity relative to the surrounding normal-appearing 
white matter.
Study participants
A total of 10 patients (3 males and 7 females; mean age = 
53 ± 7) with clinically definite relapsing–remitting MS 
Figure 1. (a) T1w image in an MS patient and (b) the 
corresponding pseudo-T1 image produced from the subtraction 
of the late echo from the early echo, in a conventional FSE dual-
echo data-set that was acquired in the same scanning session. 
White arrows indicate the presence of MS lesions.
FSE: fast-spin echo; MS: multiple sclerosis; T1: T1-weighted.
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(RRMS) and an Expanded Disability Status Scale (EDSS)13 
median score of 1.5 (range 0–2.5) were recruited and then 
scanned, using a GE Signa 1.5T MRI system (General 
Electric, Milwaukee, WI, USA) and an 8-channel phased-
array receive head coil. Scanning was approved by the local 
ethics review board and written informed consent was 
obtained from all study participants.
MR imaging
We acquired the following two-dimensional (2D) 
sequences, all with a 24 x 24 cm field of view (FOV), a 
matrix size of 256 x 256 and coverage of 28 x 5 mm slices:
1. Dual-echo FSE for the acquisition of PDw and T2w 
images with TR = 2000ms; TE1/2 = 19/95 ms; 
number of excitations (NEX) = 1 and echo-train 
length (ETL) = 8 (these images were also used to 
calculate T2 maps based on a two-point 
estimation)14;
2. An interleaved dual-echo spin-echo sequence for 
MTR calculation with TR = 1720 ms; TE1/2 = 
30/80 ms; both echoes with and without an MT 
pulse; NEX = 0.75. MTR maps were then calcu-
lated from the short echo data15;
3. Two gradient-echo sequences used for calculating 
T1 maps, as previously described16 (1st acquisition: 
TR = 1500 ms; TE = 11 ms; flip angle 45; NEX = 
1.5 and 2nd acquisition: TR = 50 ms; TE = 11 ms; 
flip angle 45; NEX = 3).
Image analysis protocol
The following processing pipeline was employed:
ADIMA region masks
1. Brain extraction using BET17 (http://www.fmrib.
ox.ac.uk/fsl/); BET was initially applied to the PDw 
images and the resultant binary mask was also 
applied to the T2w images prior to the calculation of 
the ADIMA images.
2. ADIMA images were calculated as described above 
(see equations (1) and (2)), using a commercial 
software package (MATLAB 6, TheMathWorks 
Inc., Natick, MA).
3. Contours were drawn around the outer margins of 
the dark regions seen on the ADIMA images (i.e. 
ADIMA-d regions) by one rater, using a well-
established semi-automated technique;18 the origi-
nal PDw and T2w images were used as a reference 
during the segmentation process, although dark 
regions seen on the ADIMA images were seg-
mented irrespective of the appearance on the PDw 
and T2w images, i.e. T2-WML. This was done in 
order to account for the possibility that ADIMA 
images could depict additional (or fewer) abnormal 
white matter regions than usually defined by 
T2-WML.
4. Step 3 was repeated for the outer margin of bright 
regions (i.e. ADIMA-b regions) seen on the ADIMA 
images, to obtain the ADIMA-b mask.
5. Dark regions often surrounded bright (ADIMA-b) 
regions and so the ADIMA-d mask was thereafter 
obtained from a subtraction of the masks obtained 
in step 4 from step 3.
6. The sum of ADIMA-b and ADIMA-d masks (i.e. 
the ‘combined’ or ADIMA-c mask) was also 
obtained, for use in subsequent statistical analyses.
Figure 2. (a) PDw image in an MS patient with the corresponding (b) T2w image and (c) ADIMA image. The dotted white arrow 
shows the same hyperintense MS lesion across all image types, whereas the solid white arrow shows a hyperintense lesion on both 
PDw and T2w images, which has been classified into separate ADIMA-b and ADIMA-d regions.
ADIMA-b: Advanced image algebra-bright regions; ADIMA-d: Advanced image algebra-dark regions; MS: multiple sclerosis; PDw: proton density-weighted; 
T2w:  T2-weighted
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Conventional region masks:
1. T2-WML masks were obtained for comparison with 
the ADIMA-derived masks. T2-WML masks were 
obtained from PDw and T2w images by the same 
rater, using the same semi-automated technique 
employed for obtaining the ADIMA masks.
2. Masks were also obtained from the corresponding 
2D gradient-echo T1w images (i.e. T1-WML) and 
pseudo-T1 images (i.e. psT1-WML) by the same 
rater, also using the same segmentation method.
3. NAWM regions were sampled for comparisons; 
two rectangular regions of a fixed size and volume 
(total 0.8 ml) were positioned in similar anatomical 
locations (within NAWM) in all 10 subjects who 
took part in the study.
The ADIMA-b, ADIMA-d, ADIMA-c, T2-WML, 
T1-WML and psT1-WML binary masks were also used to 
determine the percentage overlap between the various 
region types (i.e. to determine co-localisation).
Quantitative MR analyses
1. All quantitative scans were registered to the PDw 
scan using a normalised mutual information cost 
function,19 so that all the images and resultant 
parameter maps were in the PDw and T2w (hence 
ADIMA) image space.
2. MTR maps were calculated from the non- and 
MT-weighted scans using in-house developed soft-
ware based on a previously-described method.15 
ADIMA-b, ADIMA-d ADIMA-c, T2-WML, 
T1-WML, psT1-WML and NAWM masks were 
applied to the MTR maps and the mean ± standard 
deviation (SD) values were measured for each mask.
3. T1 parameter maps were calculated from the two 
gradient-echo scans as previously described16 and 
regional masks were applied, as in step 2.
4. T2 parameter maps were calculated based on a two-
point estimation14 but there was no need for the reg-
istration step for the T2 maps, as these were 
generated from the same data-set used for calculat-
ing the ADIMA images.
Reproducibility assessment
We assessed intra-observer reproducibility of the segmen-
tation method for the ADIMA-b regions, ADIMA-d regions 
and T2-WML by repeating the semi-automated segmenta-
tion process 2-times in five patients, using the same rater, 
with a gap of 1 month in between measurements. We 
assessed inter-observer reproducibility for the same region 
types with a second rater, who analysed the data from 
the same five patients, using the same semi-automated 
segmentation process. The second rater was blinded to the 
results of the first rater.
Statistical analyses
Data analysis was performed using the SPSS 11.0 statistical 
package (SPSS, Chicago, IL, USA) and Stata 12.1 (Stata 
Corporation, College Station, TX, USA). We assessed the 
relationships between conventional lesion volumes and the 
ADIMA-derived volumes using the Pearson product-
moment correlation coefficients (PCC). The intra- and 
inter-observer coefficients of variation (COV) of the vol-
ume measurements for the ADIMA-b, ADIMA-d and con-
ventional T2-WML, expressed as a percentage, were 
calculated using the mean and SD from the repeated meas-
ures using equation (3).
COV = 100 x (within subject SD/mean) (3)
For the purpose of estimating the intra- and inter-observer 
agreement, the intra-class correlation coefficient (ICC) was 
also calculated, as the between subject variance divided by 
the sum of the between subject and within subject variance: 
This is interpretable as the proportion of variability due to 
biological rather than rater variation.
Repeated measures one-way analysis of variance 
(ANOVA) was used to compare the ADIMA-b, ADIMA-d, 
ADIMA-c, T2-WML, T1-WML, psT1-WML and NAWM 
volumes in terms of the T1, T2 and MTR quantitative 
measurements (i.e. a comparison of means), after checking 
that the variables were normally distributed. We obtained 
post-hoc pair-wise multiple comparisons between the 
groups, with p-values inflated using the Sidak adjustment20 
for multiple comparisons, and we accepted significance at 
p < 0.05. We also performed an exploratory assessment of 
the possible correlations between EDSS and individual 
lesion volumes (conventional and ADIMA-derived), using 
the Spearman’s rank correlation.
Results
Our ADIMA images had enhanced signal heterogeneity 
within WML (Figure 2), but also enabled the classification 
of individual WML as being of either of the ADIMA-b or 
ADIMA-d type (Figure 3). In addition, ADIMA-b regions 
occasionally exhibited a hypointense rim surrounding them 
(i.e. classified as ADIMA-d in this case), which could not be 
depicted on the individual PDw or T2w images (Figure 4). 
Two (n = 2) patients out of the 10 patients investigated in 
this study had no ADIMA-b regions present in their images, 
but in those same patients we found all other region types 
present. All remaining patients (n = 8) had all the region 
types present in their images.
Mean volume measurements of the various region 
types (i.e. calculated across all patients) showed that the 
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ADIMA-derived volumes combined (i.e. mean ADIMA-c) 
exceeded the mean T2-WML volume. This meant that the 
ADIMA-derived regions included additional pathological 
regions than usually defined as T2-WML (i.e. with the 
semi-automated segmentation method used in this study). A 
breakdown of the results showed that ADIMA-b had the 
lowest volume, followed by the T1-WML, psT1-WML, 
T2-WML, ADIMA-d and ADIMA-c. Table 1 shows the 
mean volumes of all the region types along with significant 
correlations identified from pair-wise comparisons using 
the PCC. The mean intra-observer COV and ICC of the 
segmentation method used for measuring the ADIMA-b, 
ADIMA-d and T2-WML volumes were calculated as COV 
= 4.9%, 5.8%, 4.7% and ICC = 0.91, 0.92, 0.92, respec-
tively. The mean inter-observer COV and ICC for the 
ADIMA-b, ADIMA-d and T2-WML were calculated as 
Figure 3. (a) T2w image in an MS patient with the patient’s corresponding (b) T1w image and (c) ADIMA image. The solid white 
arrow shows a MS lesion that can be seen on both T2w and T1w images and which appeared bright on the ADIMA image, whereas 
the dotted white arrow shows a similar lesion that appeared dark on the ADIMA image.
ADIMA: advanced image algebra; MS: multiple sclerosis; T1w: T1-weighted; T2w: T2-weighted
Figure 4. The top row in the figure shows (a) a PDw image with the corresponding (b) T2w image and (c) ADIMA image. The bottom 
row shows a magnified section of each image type, respectively. The solid white arrows show the hyperintense MS lesions on the 
PDw and T2w images that appeared hypointense on the ADIMA image (ADIMA-d) and the dotted white arrow shows a hyperintense 
lesion on the PDw and T2w images that appeared mostly hyperintense on the ADIMA image (ADIMA-b), but with a hypointense rim 
surrounding it (classified as being of the ADIMA-d type).
ADIMA-b: advanced image algebra, bright region; ADIMA-d: advanced image algebra, dark region; MS: multiple sclerosis; PDw: proton density-weighted; T2w: 
T2-weighted
 at University College London on August 4, 2014msj.sagepub.comDownloaded from 
Yiannakas et al. 737
COV = 8.1%, 9.3%, 7.6% and ICC = 0.86, 0.87, 0.87, 
respectively.
The overlap of the various binary region masks showed 
that the ADIMA-b regions were almost entirely contained 
within T2-WML, and that they only partly overlapped with 
T1-WML and psT1-WML. ADIMA-d regions overlapped 
mainly with T2-WML, whereas the percent overlap of 
these regions with either the T1-WML or psT1-WML, was 
found to be considerably lower. T2-WML, T1-WML and 
psT1-WML were each found to be mostly contained within 
the ADIMA-c. Table 2 shows the results from all the binary 
region mask overlaps.
Quantitative MR measurements showed that the 
ADIMA-b regions had significantly higher T2 and signifi-
cantly lower MTR than any of the other region types. In 
addition, ADIMA-b regions were found to have signifi-
cantly higher T1 than any other region apart from T1-WML.
ADIMA-d regions were found to have intermediate T1, 
T2 and MTR values to T2-WML and NAWM; however, the 
differences in T1, T2 and MTR values between ADIMA-d 
and T2-WML were not significant, whereas the differences 
in each of these measures between ADIMA-d and NAWM 
were found to be significant. In addition, ADIMA-d regions 
were found to have a significant difference in T1, T2 and 
MTR values, when compared with either the T1-WML or 
psT1-WML.
ADIMA-c regions were also found to have intermediate 
T1, T2 and MTR values to T2-WML and NAWM. The dif-
ferences in T1, T2 and MTR values between ADIMA-c and 
T2-WML, however, were not significant, whereas the dif-
ferences in each of these measures between ADIMA-c and 
NAWM were found to be significant. In addition, ADIMA-c 
regions were found to have significant differences in T1 
and MTR values, when compared with either the T1-WML 
Table 1. Mean volume measurements and pair-wise correlations between region types.a
Region Volume Pearson Correlations
Significant pair-wise correlations between regions R value P value
ADIMA-b
(n = 8)
 1.8 ml ADIMA-b versus T2-WML
ADIMA-b versus T1-WML
ADIMA-b versus psT1-WML
0.90
0.89
0.88
p = 0.002
p = 0.003
p = 0.004
ADIMA-d
(n = 10)
10.6 ml ADIMA-d versus T2-WML
ADIMA-d versus T1-WML
ADIMA-d versus psT1-WML
0.99
0.91
0.81
p < 0.001
p < 0.001
p = 0.004
ADIMA-c
(n = 10)
14.4 ml ADIMA-c versus T2-WML
ADIMA-c versus T1-WML
ADIMA-c versus psT1-WML
0.99
0.92
0.81
p < 0.001
p < 0.001
p = 0.014
T2-WML
(n = 10)
10.1 ml T2-WML versus T1-WML
T2-WML versus psT1-WML
0.94
0.88
p < 0.001
p = 0.02
T1-WML
(n = 10)
 3.3 ml T1-WML versus psT1-WML 0.95 p < 0.001
psT1-WML
(n = 10)
 3.5 ml – – –
NAWM
(n = 10)
 0.8 ml – – –
aAveraged volumes for each region are given for the entire group of patients by multiplying the total number of voxels with the voxel volume.
ADIMA: Advanced image algebra; T1: T1-weighted; T2: T2-weighted; WML: white matter lesion.
Table 2. Mean % overlap between the different region types.a
Region Type ADIMA-b ADIMA-d ADIMA-c T2-WML T1-WML psT1-WML
ADIMA-b 100 – 100 90.4 67 67.2
ADIMA-d – 100 100 60.8 16.3 14.5
ADIMA-c 18.4 81.6 100 65.5 23.3 22.1
T2-WML 20.1 65 79.3 100 33.6 28.7
T1-WML 38.9 44.5 77.6 80.2 100 46.5
psT1-WML 53.4 32.6 80.1 75.7 52 100
aThe region types shown on the left (first column) represent the reference tissue with which comparisons can be made. For example, we saw that 
90.4% of ADIMA-b contains T2-WML, whereas only 20.1% of T2-WML contains ADIMA-b. 
ADIMA: advanced image algebra; T1: T1-weighted; T2:T2-weighted WML: white matter lesion
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or the psT1-WML, but no significant differences were 
found in T2 values between these regions.
Table 3 shows all the results from the quantitative meas-
urements pertaining to each region type, while Table 4 
shows the results from the statistical comparison between 
all region types, in terms of the quantitative measurements.
The results from the exploratory assessment looking 
into possible correlations between lesion volumes and 
EDSS were not significant.
Discussion
MS WML are pathologically heterogeneous, with differing 
degrees of inflammation, demyelination, remyelination, 
axonal loss and gliosis observed.21,22 While PDw and T2w 
MR images are especially sensitive in the detection of MS 
WML (i.e. T2-WML), they are not pathologically specific. 
Furthermore, the correlation between T2-WML volume 
and clinical disability of patients with MS is very weak, 
resulting in what is commonly known as a clinico-radio-
logic paradox.1
ADIMA is a novel post-processing method that utilises 
conventional PDw and T2w images in order to improve the 
dynamic range of signal intensities in these images, by 
means of image algebra. This study showed that in MS 
patients, ADIMA provides a simple and reproducible clas-
sification of WML, seen on PDw and T2w images as 
ADIMA-b, ADIMA-d and ADIMA-c sub-regions that can 
be easily segmented, with a reproducibility of segmentation 
comparable with other studies.23 Importantly, this study 
Table 3. Quantitative MRI measurements for each region type.
Measurement ADIMA-b  
(n = 8)
ADIMA-d  
(n = 10)
ADIMA-c  
(n = 8)
T2-WML  
(n =10)
T1-WML  
(n = 10)
PseudoT1-
WML (n = 10)
NAWM  
(n = 10)
T1, mean (SD), ms 1225 (216.7) 870.1 (175.3) 917.1 (230.4) 956.2 (215.4) 1102.7 (231.6) 1076.3 (241.5) 632.8 (47.0)
T2, mean (SD), ms 213.2 (71.9) 118.5 (20.3) 130.4 (48.8) 134.2 (44.2) 156.4 (57.5) 167.2 (54.5) 79.3 (4.4)
MTR, mean (SD), % 23.8 (4.4) 32.3 (3.5) 31.4 (4.9) 30.5 (4.6) 28.1 (5.3) 27.8 (5.6) 39.7 (1.6)
ADIMA: advanced image algebra; MRI: magnetic resonance imaging; MTR: magnetisation transfer ratio; NAWM: normal-appearing white matter; T1: T1-
weighted; T2: T2-weighted; WML: white matter lesion
Table 4. Statistical comparison of all the region types in terms of the quantitative measurements.a
Region type Post-hoc tests One-way ANOVA test analyses
p values
T1 T2 MTR
ADIMA-b ADIMA-b vs. ADIMA-d
ADIMA-b vs. ADIMA-c
ADIMA-b vs. T2-WML
ADIMA-b vs. T1-WML
ADIMA-b vs. psT1-WML
ADIMA-b vs. NAWM
p < 0.001
p < 0.001
p < 0.001
p = 0.051
p = 0.006
p < 0.001
p < 0.001
p < 0.001
p < 0.001
p < 0.001
p = 0.02
p < 0.001
p < 0.001
p < 0.001
p < 0.001
p < 0.001
p < 0.001
p < 0.001
ADIMA-d ADIMA-d vs. ADIMA-c
ADIMA-d vs. T2-WML
ADIMA-d vs. T1-WML
ADIMA-d vs. psT1-WML
ADIMA-d vs. NAWM
p = 0.99
p = 0.30
p < 0.001
p < 0.001
p < 0.001
p = 0.99
p = 0.99
p = 0.05
p = 0.03
p = 0.04
p = 0.99
p = 0.50
p < 0.001
p < 0.001
p < 0.001
ADIMA-c ADIMA-c vs. T2-WML
ADIMA-c vs. T1-WML
ADIMA-c vs. psT1-WML
ADIMA-c vs. NAWM
p = 0.99
p < 0.001
p < 0.001
p < 0.001
p = 0.99
p = 0.50
p = 0.08
p = 0.006
p = 0.99
p = 0.008
p = 0.003
p < 0.001
T2-WML T2-WML vs. T1-WML
T2-WML vs. psT1-WML
T2-WML vs. NAWM
p < 0.001
p = 0.02
p < 0.001
p = 0.08
p = 0.20
p < 0.001
p = 0.10
p = 0.004
p < 0.001
T1-WML T1-WML vs. psT1-WML
T1-WML vs. NAWM
p = 0.99
p < 0.001
p = 0.99
p < 0.001
p = 0.99
p < 0.001
aANOVA test results for each region type with post-hoc pair-wise comparison. The p-values are inflated, using the Sidak adjustment for 
multiple comparisons, which can be used when subjects have missing values (two study patients did not have visible ADIMA-b lesions in 
their scans).
ADIMA: advanced image algebra; ANOVA: analysis of variance; NAWM: normal-appearing white matter; psT1: pseudo-T1; T1: T1-weighted; T2: T2-
weighted; WML: white matter lesion
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suggests that the sub-types of ADIMA differ in their bal-
ance of pathology, as was demonstrated by quantitative 
MRI, and as such they provide information that had not 
previously been extracted from the original PDw and T2w 
scans. While the ventricles and some lesions have a thin 
dark rim, which appears to be related to partial volume 
within these voxels, the ADIMA-d lesions show a higher 
MTR and lower relaxation times than the ADIMA-b 
lesions, which suggested that their fluid content is lower, 
indicating that the ADIMA method is detecting pathologi-
cally-related processes. Furthermore, on inspection of the 
ADIMA images, no systematic artefacts were observed. It 
is worth noting that both the blood vessels and perivascular 
spaces (i.e. Virchow-Robin) are visible on the ADIMA 
images with reversed contrast, as compared to the PDw 
images; however, they are no more conspicuous on the 
ADIMA images than on the PDw images.
By considering the results of each ADIMA-derived 
region individually, some interesting observations can be 
made. Looking at the results pertaining to the ADIMA-b 
regions, for example, it becomes evident that these regions 
are likely to represent highly destructive pathological 
regions in white matter that are mainly subsets of T2-WML. 
The high T1 and T2 values, as well as the low MTR values 
within these regions, suggest that the underlying tissue 
damage is likely to be severe and most likely is contributing 
to conduction impairment and deficit in a similar way to the 
T1-WML.24–27 However, ADIMA-b regions are only partly 
contained within T1-WML. In addition, ADIMA-b regions 
were not present in two out of the 10 patients, while these 
two patients did have T1-WML. This shows that ADIMA-b 
and T1-WML are not entirely equivalent, which is further 
supported by the significant MTR and T2-relaxation time 
differences observed (Table 4). Perhaps the investigation of 
ADIMA-b regions alongside T1-WML in the future may 
become key in establishing any possible correlations with 
disability, and further studies should aim to test this 
hypothesis.
The ADIMA-d regions appear to have similar underly-
ing characteristics to T2-WML. Although not significantly 
different, both T1 and T2 values were found to be slightly 
lower and the MTR slightly higher in the ADIMA-d regions 
than in the T2-WML. This observation can be explained by 
the fact that a portion of T2-WML may also include 
ADIMA-b (i.e. regions of much higher T1 and T2, and 
much lower MTR), which can influence the quantitative 
measurements obtained within these regions. Perhaps an 
important quality pertaining to ADIMA-d regions is related 
to the observation that these regions have highlighted addi-
tional pathological areas in white matter than T2-WML 
showed (i.e. with the segmentation method used in this 
study). This is further supported by considering the mean 
ADIMA-c volume, which was found to be much greater 
than T2-WML. A plausible explanation is related to the fact 
that ADIMA images are calculated using both PDw and 
T2w images, which means that ADIMA images are sensi-
tive to both changes in relaxation of tissue. In vivo studies 
show that white matter tissue damage exists beyond the 
T2-WML areas, so further investigation will be required to 
determine what the additional pathological white matter 
areas that are detected on the ADIMA images truly 
represent.
Using the ADIMA method, we have detected lesions 
with a hypointense rim surrounding a bright core, some-
thing that was not seen on the PDw and T2w images. T2 
hypointense rims in MS WML have been reported previ-
ously in both pathological28 and MRI studies.29,30 The fre-
quency of rim lesions in a large, unselected cohort of MS 
patients was found to be 9%; these lesions were also found 
to be associated with gadolinium ring-enhancing lesions, 
although both lesion types could also be present indepen-
dently.29 Furthermore, the RRMS patients in the same study 
were found to have the highest number of these types of 
lesions compared to any other MS disease subtype, with 
neither observed in patients with the primary progressive 
MS (PPMS) disease subtype. This may explain why the 
lesions with hypointense rim were observed in this study of 
10 RRMS patients, although it was not possible to deter-
mine whether the hypointensities seen on the ADIMA 
images represent T2 hypointense rim lesions and/or were 
associated with ring-enhancing lesions. Further investiga-
tions to determine the power of ADIMA to detect specific 
types of MS lesions will be required.
In this study, psT1-WML volumes were also measured, 
in order to compare these with the newly-derived ADIMA 
regions, as well as to determine their associations with 
T1-WML. By considering mean volumes between 
T1-WML and psT1-WML, we found these were both very 
similar (3.5 ml and 3.3 ml, respectively), although this find-
ing is somewhat different from the original report showing 
that the mean psT1-WML area was almost half the mean 
T1-WML area in 17 MS patients.12 However, in this study 
RRMS patients were investigated, whereas data from sec-
ondary progressive MS (SPMS) patients were analysed in 
the original study, so this may have influenced the results. 
Further studies, specifically addressing each MS disease 
subtype, will help us to understand the relationships 
between psT1-WML, T1-WML and ADIMA-derived 
regions.
Based on the results from the exploratory assessment 
looking into possible correlations between EDSS and indi-
vidual lesion volumes, it was found they were not signifi-
cant. This is not surprising, considering the small number 
of patients in this study and the extremely narrow EDSS 
range (0–2.5). Further investigation using larger cohorts of 
patients and covering a wider range of disability scores, 
including specific measurements like the MS functional 
composite MSFC measure,31 are recommended in order to 
reliably determine any clinical correlations. Also, it would 
be interesting to assess the temporal evolution of ADIMA-b 
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and ADIMA-d lesions in longitudinal studies of patients 
with MS, to assess any potential for prediction of disease 
progression.
In summary, ADIMA is presented as a new post-pro-
cessing method that enables a simple classification of 
WML into two groups, with different quantitative MR 
properties, that can be reproducibly segmented. Future 
work to understand the nature of the ADIMA-derived 
regions in MS could include post-mortem investigations 
with matching histopathologic correlates. Furthermore, 
investigations of the behaviour of the ADIMA method at 
higher magnetic field strengths may also be useful in fur-
ther defining the method in vivo. A larger clinical study that 
includes all MS clinical subgroups is warranted as well, to 
understand clinical correlations with the new ADIMA-
derived regions. Studies of other white matter diseases 
could help assess whether the ADIMA method might some-
day be helpful in providing a differential diagnosis. A facil-
itating characteristic of the ADIMA method in this respect, 
is that it can actually be applied retrospectively, to already 
available MR data-sets.
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